Asthma
Authors: Meeta Prasad Kerlin
Journal: Annals of Internal Medicine (2014)

In the Clinic4 March 2014AsthmaMeeta Prasad Kerlin, MD, MSCE, Deborah Cotton, MD, MPH, Darren Taichman, MD, PhD, and Sankey Williams, MDMeeta Prasad Kerlin, MD, MSCESearch for more papers by this author, Deborah Cotton, MD, MPHSearch for more papers by this author, Darren Taichman, MD, PhDSearch for more papers by this author, and Sankey Williams, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-160-5-201403040-01003 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Asthma is a common respiratory illness characterized by airway hyperresponsiveness and inflammation. It affects over 300 million people globally (1), including 22 million adults in the United States alone. Although asthma mortality in the United States has declined, the morbidity and costs remain substantial. In certain groups of Americans, such as persons of lower socioeconomic status and minority ethnicity, asthma morbidity and mortality are disproportionately high. Such trends are surprising, given the improvement in air quality in the United States and the availability of effective therapies.DiagnosisWhat symptoms or elements of clinical history are helpful in diagnosing asthma?Symptoms that ...References1. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. [PMID: 22429515] Google Scholar2. Li JT, O'Connell EJ. Clinical evaluation of asthma. Ann Allergy Asthma Immunol. 1996;76:1-13; quiz 13-5. [PMID: 8564622] Google Scholar3. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120:S94-138. [PMID: 17983880] Google Scholar4. McFadden ER Jr, Kiser R, DeGroot WJ. Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med. 1973;288:221-5. [PMID: 4682217] Google Scholar5. Shim CS, Williams MH Jr. Relationship of wheezing to the severity of obstruction in asthma. Arch Intern Med. 1983;143:890-2. [PMID: 6679232] Google Scholar6. Chetta A, Gerra G, Foresi A, Zaimovic A, Del Donno M, Chittolini B, et al. Personality profiles and breathlessness perception in outpatients with different gradings of asthma. Am J Respir Crit Care Med. 1998;157:116-22. [PMID: 9445288] Google Scholar7. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-87. [PMID: 9872837] Google Scholar8. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-68. [PMID: 16264058] Google Scholar9. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319-38. [PMID: 16055882] Google Scholar10. Swanney MP, Jensen RL, Crichton DA, Beckert LE, Cardno LA, Crapo RO. FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med. 2000;162:917-9. [PMID: 10988105] Google Scholar11. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309-29. [PMID: 10619836] Google Scholar12. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235-43. [PMID: 908121] Google Scholar13. Hopp RJ, Bewtra AK, Nair NM, Townley RG. Specificity and sensitivity of methacholine inhalation challenge in normal and asthmatic children. J Allergy Clin Immunol. 1984;74:154-8. [PMID: 6747136] Google Scholar14. Perpiñá M, Pellicer C, de Diego A, Compte L, Macián V. Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest. 1993;104:149-54. [PMID: 8325060] Google Scholar15. Jain P, Kavuru MS, Emerman CL, Ahmad M. Utility of peak expiratory flow monitoring. Chest. 1998;114:861-76. [PMID: 9743179] Google Scholar16. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58:659-64. [PMID: 12885978] Google Scholar17. Irwin RS, Curley FJ, French CL. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. Chest. 1993;103:1662-9. [PMID: 8404082] Google Scholar18. Althuis MD, Sexton M, Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma. 1999;36:257-64. [PMID: 10350222] Google Scholar19. Weiss ST, Utell MJ, Samet JM. Environmental tobacco smoke exposure and asthma in adults. Environ Health Perspect. 1999;107 Suppl 6:891-5. [PMID: 10592149] Google Scholar20. Ho G, Tang H, Robbins JA, Tong EK. Biomarkers of tobacco smoke exposure and asthma severity in adults. Am J Prev Med. 2013;45:703-9. [PMID: 24237911] Google Scholar21. Ostro BD, Lipsett MJ, Mann JK, Wiener MB, Selner J. Indoor air pollution and asthma. Results from a panel study. Am J Respir Crit Care Med. 1994;149:1400-6. [PMID: 8004290] Google Scholar22. Institute of Medicine Committee on the Assessment of Asthma and Indoor Air. Executive summary. In: Clearing the Air: Asthma and Indoor Air Exposures. Washington, DC: National Academies Pr; 2000. Google Scholar23. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144:904-12. [PMID: 16754916] Google Scholar24. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet. 1994;344:219-24. [PMID: 7913155] Google Scholar25. Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur Respir J. 1997;10:2754-60. [PMID: 9493656] Google Scholar26. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med. 1996;153:1481-8. [PMID: 8630590] Google Scholar27. Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol. 2000;106:1088-95. [PMID: 11112891] Google Scholar28. Löfdahl CG, Reiss TF, Leff JA, Israel E, Noonan MJ, Finn AF, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319:87-90. [PMID: 10398629] Google Scholar29. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med. 1999;160:1862-8. [PMID: 10588598] Google Scholar30. Ducharme FM, Lasserson TJ, Cates CJ. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev. 2006:CD003137. [PMID: 17054161] Google Scholar31. Kerstjens HA, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012;367:1198-207. [PMID: 22938706] Google Scholar32. Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005;60:309-16. [PMID: 15679715] Google Scholar33. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368:2455-66. [PMID: 23688323] Google Scholar34. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129:15-26. [PMID: 16424409] Google Scholar35. Nelson JA, Strauss L, Skowronski M, Ciufo R, Novak R, McFadden ER Jr. Effect of long-term salmeterol treatment on exercise-induced asthma. N Engl J Med. 1998;339:141-6. [PMID: 9664089] Google Scholar36. Nightingale JA, Rogers DF, Barnes PJ. Comparison of the effects of salmeterol and formoterol in patients with severe asthma. Chest. 2002;121:1401-6. [PMID: 12006420] Google Scholar37. Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med. 1998;339:147-52. [PMID: 9664090] Google Scholar38. Emerman CL, Woodruff PG, Cydulka RK, Gibbs MA, Pollack CV Jr, Camargo CA Jr. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest. 1999;115:919-27. [PMID: 10208187] Google Scholar39. McCarren M, McDermott MF, Zalenski RJ, Jovanovic B, Marder D, Murphy DG, et al. Prediction of relapse within eight weeks after an acute asthma exacerbation in adults. J Clin Epidemiol. 1998;51:107-18. [PMID: 9474071] Google Scholar40. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281:2119-26. [PMID: 10367823] Google Scholar41. Effectiveness of routine self monitoring of peak flow in patients with asthma. Grampian Asthma Study of Integrated Care (GRASSIC). BMJ. 1994;308:564-7. [PMID: 8148679] Google Scholar42. Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ. 1990;301:1355-9. [PMID: 2148702] Google Scholar Author, Article, and Disclosure InformationAuthors: Meeta Prasad Kerlin, MD, MSCE; Deborah Cotton, MD, MPH; Darren Taichman, MD, PhD; Sankey Williams, MDCME Objective: To review current evidence for diagnosis, treatment, and practice improvement of asthma.Funding Source: American College of Physicians.Disclosures: Dr. Kerlin, ACP Contributing Author, has disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-0862.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer.With the assistance of additional physician writers, Annals of Internal Medicine editors develop In the Clinic using resources of the American College of Physicians, including ACP Smart Medicine and MKSAP (Medical Knowledge and Self-Assessment Program). PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byTherapeutic Effects of Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on a Murine Model of Acute Type-2-Dominated Airway Inflammation 4 March 2014Volume 160, Issue 5Page: ITC3-1KeywordsAsthmaBronchodilatorsEmergency departmentExerciseForced expiratory volume in the first second of expirationHealth care qualityLungsPulmonary functionSpirometryThorax ePublished: 4 March 2014 Issue Published: 4 March 2014 Copyright & PermissionsCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...